1998-07-09T00:00:00
The Alzheimer's Disease Society has challenged researchers' claims that new drug therapies could effectively pay for themselves by keeping patients out of institutional care.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud